You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

AMPICILLIN Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Ampicillin patents expire, and what generic alternatives are available?

Ampicillin is a drug marketed by Acs Dobfar, Antibiotice, Astral, Eugia Pharma Speclts, Hikma, Hospira Inc, Hq Speclt Pharma, Istituto Bio Ita Spa, Medimetriks Pharms, Sandoz, Steriscience Speclts, Acs Dobfar Spa, Apothecon, Consolidated Pharm, Hospira, Intl Medication, Lilly, Sagent Pharms Inc, Watson Labs Inc, Aurobindo Pharma, Belcher Pharms, Chartwell Rx, Ivax Sub Teva Pharms, Lederle, Mylan, Purepac Pharm, Strides Pharma, Vitarine, Endo Operations, and Teva. and is included in sixty-four NDAs.

The generic ingredient in AMPICILLIN is ampicillin/ampicillin trihydrate. Three suppliers are listed for this compound. Additional details are available on the ampicillin/ampicillin trihydrate profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for AMPICILLIN?
What are the global sales for AMPICILLIN?
What is Average Wholesale Price for AMPICILLIN?

Summary for AMPICILLIN

US Patents:	0
Applicants:	30
NDAs:	64
Drug Prices:	Drug price information for AMPICILLIN
Drug Sales Revenues:	Drug sales revenues for AMPICILLIN
DailyMed Link:	AMPICILLIN at DailyMed

Drug patent expirations by year for AMPICILLIN

Drug Prices for AMPICILLIN

US Patents and Regulatory Information for AMPICILLIN

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	AMPICILLIN SODIUM	ampicillin sodium	INJECTABLE;INJECTION	202864-002	Sep 4, 2015		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sandoz	AMPICILLIN SODIUM	ampicillin sodium	INJECTABLE;INJECTION	061395-006	Approved Prior to Jan 1, 1982	AP	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Acs Dobfar Spa	AMPICILLIN SODIUM	ampicillin sodium	INJECTABLE;INJECTION	090884-001	Apr 3, 2013		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sandoz	AMPICILLIN AND SULBACTAM	ampicillin sodium; sulbactam sodium	INJECTABLE;INJECTION	065241-002	Jul 25, 2006	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Istituto Bio Ita Spa	AMPICILLIN SODIUM	ampicillin sodium	INJECTABLE;INJECTION	201404-001	Dec 20, 2013	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.